Literature DB >> 12795756

Preclinical study of endoscopic ultrasonography with electronic radial scanning echoendoscope.

Katsushi Niwa1, Yoshiki Hirooka, Akihiro Itoh, Senju Hashimoto, Takanori Hirai, Kinichi Takeda, Hidemi Goto.   

Abstract

BACKGROUND: To evaluate the imaging possibility of a newly designed electronic radial scanning echoendoscope (ER-ES).
METHODS: In the in vivo study of swine, we obtained B-mode endoscopic ultrasonography (EUS) images of the gastric and gallbladder (GB) walls and checked the ability to detect Doppler signals using ER-ES and electronic linear array echoendoscope (EL-ES). Furthermore, in the ex vivo study of swine, B-mode EUS images of fixed gastric and GB wall specimens were obtained using ER-ES, EL-ES and mechanical radial scanning echoendoscope (MR-ES). In the study of resected human specimens, we obtained B-mode EUS images of five resected GB specimens (three normal GB, one cholecystitis and one cancerous) using the three types of echoendoscope.
RESULTS: In the in vivo study of swine, ER-ES and EL-ES depicted the gastric walls as five-layered, and the GB walls as single-layered structures. The ability to detect Doppler signals was equal between ER-ES and EL-ES. In the ex vivo study of swine, ER-ES, MR-ES and EL-ES equally delineated the gastric walls as five-layered and GB walls as three-layered structures. In the study of resected human specimens, results demonstrated the normal GB walls as three-layered, the cholecystitis as a combination of outer high-echoic and inner low-echoic layers, and the cancer as a protruded tumor.
CONCLUSIONS: We conclude that ER-ES has faculties for making B-mode images as well as EL-ES and MR-ES. In addition, in the in vivo study, ER-ES can analyze blood flow information as well as EL-ES. Copyright 2003 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Year:  2003        PMID: 12795756     DOI: 10.1046/j.1440-1746.2003.03045.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Clinical oncology for pancreatic and biliary cancers: Advances and current limitations.

Authors:  Yoshiki Hirooka; Akihiro Itoh; Hiroki Kawashima; Eizaburo Ohno; Takuya Ishikawa; Yuya Itoh; Yosuke Nakamura; Takeshi Hiramatsu; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto
Journal:  World J Clin Oncol       Date:  2011-05-10

Review 2.  Contrast-enhanced endoscopic ultrasonography in digestive diseases.

Authors:  Yoshiki Hirooka; Akihiro Itoh; Hiroki Kawashima; Eizaburo Ohno; Yuya Itoh; Yosuke Nakamura; Takeshi Hiramatsu; Hiroyuki Sugimoto; Hajime Sumi; Daijiro Hayashi; Naoki Ohmiya; Ryoji Miyahara; Masanao Nakamura; Kohei Funasaka; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

Review 3.  What should be known prior to performing EUS exams? (Part II).

Authors:  Christoph F Dietrich; Paolo Giorgio Arcidiacono; Barbara Braden; Sean Burmeister; Silvia Carrara; Xinwu Cui; Milena Di Leo; Yi Dong; Pietro Fusaroli; Uwe Gottschalk; Andrew J Healey; Michael Hocke; Stephan Hollerbach; Julio Iglesias Garcia; André Ignee; Christian Jürgensen; Michel Kahaleh; Masayuki Kitano; Rastislav Kunda; Alberto Larghi; Kathleen Möller; Bertrand Napoleon; Kofi W Oppong; Maria Chiara Petrone; Adrian Saftoiu; Rajesh Puri; Anand V Sahai; Erwin Santo; Malay Sharma; Assaad Soweid; Siyu Sun; Anthony Yuen Bun Teoh; Peter Vilmann; Hans Seifert; Christian Jenssen
Journal:  Endosc Ultrasound       Date:  2019 Nov-Dec       Impact factor: 5.628

4.  Feasibility of newly developed endoscopic ultrasound with zone sonography technology for diagnosis of pancreatic diseases.

Authors:  Yoshiki Hirooka; Akihiro Itoh; Hiroki Kawashima; Eizaburo Ohno; Yuya Itoh; Yosuke Nakamura; Takeshi Hiramatsu; Hiroyuki Sugimoto; Hajime Sumi; Daijiro Hayashi; Naoki Ohmiya; Ryoji Miyahara; Masanao Nakamura; Kohei Funasaka; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.